Australia’s medical device watchdog has recommended banning texture breast implants following an exhaustive review into their links to a rare form of cancer. On Thursday, the Therapeutic Goods Administration (TGA) proposed cancelling, suspending and recalling a number of textured implant models over strong evidence that they were associated with a higher risk of anaplastic large cell lymphoma (ALCL). The textured implants have been associated with an elevated risk of anaplastic large cell lymphoma (ALCL). It recommended banning nine Allergan ‘Natrelle’ implant models, and suspending a number of implants manufactured by Johnson & Johnson, Adirel, Emagin, Emergo, Euro Implants and JT Medical. The regulator also proposed imposing conditions on Allergan’s ‘BRST’ models, as well as two more Emagin models and two JT Medical models. Federal Health Minister Greg Hunt said the government supported the TGA’s "strong and decisive" action. It follows the decision by French and Canadian regulators to ban […]